exRNAdisease

Entry Detail

---



General Information

Database ID: exR0201452 RNA Name: hsa-miR-143-3p RNA Type: miRNA Chromosome: chr5 Starnd: + Coordinate: Start Site(bp): 149428978 End Site(bp): 149428998 External Links: hsa-miR-143-3p

Disease Information

Disease Name: Mild Cognitive Impairment Disease Category: Other Diseases MeSH ID: D060825 Type: Psychiatry and Psychology Category/Mental Disorders Alias: Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations

Expression Detail

GEO ID: GSE120584 Description: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Experimental Design: Disease vs Control Case Disease Type: Alzheimer's Disease Case Disease SubType: NA Case Sample: Mild Cognitive Impairment Control Sample: Normal Number of Case: 1021 Number of Control: 288 Number of Samples: 1309

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ACVR1B chr12 51951699 51997078 + BTF3L4 chr1 52056199 52090716 + BTG2 chr1 203305491 203309602 + CAPZB chr1 19338775 19485539 - CDK6 chr7 92604921 92836594 - CELSR2 chr1 109249539 109275751 + CIT chr12 119685791 119877320 - DEGS1 chr1 224175756 224193441 + DYRK1B chr19 39825350 39834201 - EFNA3 chr1 155078837 155087538 + FOSL2 chr2 28392448 28417317 + IGFBP5 chr2 216672105 216695549 - KRIT1 chr7 92198969 92246166 - MAP3K3 chr17 63622415 63696303 + NES chr1 156668763 156677407 - PACS1 chr11 66070272 66244744 + PATL1 chr11 59636716 59669037 - PNKD chr2 218270392 218346793 + RFWD3 chr16 74621399 74666877 - SLC7A11 chr4 138164097 138242349 - SON chr21 33543038 33577481 + STARD4 chr5 111496033 111512590 - STMN3 chr20 63639705 63657682 - TATDN2 chr3 10248023 10281218 + TFPI chr2 187464230 187565760 - TIGD5 chr8 143597831 143603224 + VPS37C chr11 61130257 61161615 - WSB1 chr17 27294076 27315926 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001247 chr22 46125304 46136418 + hsa_circ_0000711 chr16 68155889 68160513 + hsa_circ_0000431 chr12 102301963 102308010 + hsa_circ_0001168 chr20 47691321 47707559 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC009022.1 chr16 69976297 70065948 - AC091564.7 chr11 6610883 6616594 - AC245884.8 chr19 54438665 54439544 - DHRS4-AS1 chr14 23938219 24052555 - LINC00667 chr18 5237826 5290608 + LZTS1-AS1 chr8 20275773 20290458 + MALAT1 chr11 65497688 65506516 + MCM3AP-AS1 chr21 46229196 46259390 + OIP5-AS1 chr15 41283990 41309737 + Display:

Experiment Detail

GEO ID: GSE120584 Sample Source: Blood Source Fraction: Serum Platform: GPL21263 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2532 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.). RNA library preparation protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

Reference

PMID: 30820472 Title: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Author: Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S Journal: Commun Biol. 2019 Feb 25;2:77. Description: we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia